Anthropic and medical knowledge platform OpenEvidence are teaming up to provide free AI-powered clinical decision support to physicians across roughly 100 low- and middle-income countries. The initiative aims to expand access to medical research and treatment guidance in places where doctors may have limited access to specialist expertise and medical literature.
The partnership is significant because it moves medical AI beyond wealthy healthcare systems and into regions where a smartphone may provide access to information that was previously available mainly through major hospitals and expensive institutional subscriptions.
The rollout includes countries such as Uganda, Angola, Sudan, Haiti and Mongolia, according to a list provided by OpenEvidence.
Table of Contents
Anthropic and OpenEvidence Are Taking Different Roles
Under the partnership, Anthropic will provide the AI infrastructure behind the system, while OpenEvidence will adapt its medical platform for different regions.
OpenEvidence is designed to answer physicians’ questions using peer-reviewed medical research and treatment guidelines. The platform is already available free to clinicians in the United States and Europe.
The companies say the international version will not simply be a copy of the system used in wealthier countries.
Instead, OpenEvidence plans to account for differences in:
- Disease patterns
- Available diagnostic equipment
- Treatment availability
- Healthcare infrastructure
- Local clinical conditions
OpenEvidence founder Daniel Nadler described the approach as fully context adaptive.
That distinction could be important. A medical recommendation that makes sense in a hospital with advanced imaging, specialist departments and reliable electricity may not be practical in a rural clinic with very different resources.
Why This Matters in Low- and Middle-Income Countries
One of the biggest potential advantages of medical AI is not replacing physicians. It is making existing medical knowledge easier to access.
Doctors in wealthier countries can often consult large medical databases, specialists and institutional subscriptions. In lower-resource settings, those resources can be harder to access.
Reuters reported that OpenEvidence was consulted by U.S. clinicians 42 million times in August alone, according to Nadler.
The international initiative attempts to bring a version of that information infrastructure to healthcare professionals who may otherwise have fewer resources available at the point of care.
Dr. Ahmed Bendary, a cardiologist at Benha University in Egypt, told Reuters that wider access could be particularly useful in regions where institutional subscriptions to major medical journals are limited.
The Smartphone Could Be the Key
There is an interesting technological reality behind the project.
Some healthcare facilities in low-resource regions may not have continuous electricity or the same equipment available in major hospitals. Yet many physicians have smartphones.
Nadler said that even where healthcare facilities lack around-the-clock electricity, most physicians have smartphones.
That creates a potential pathway for delivering sophisticated medical information without requiring every facility to have the infrastructure of a major research hospital.
In other words, the smartphone becomes the delivery mechanism for a much larger medical knowledge system.
OpenEvidence Has Already Tested Local Adaptation
The international rollout is not starting entirely from scratch.
Earlier this year, OpenEvidence said it had been working with healthcare organizations in Rwanda and Botswana to adapt its tools to local conditions.
The reason for that work is straightforward: healthcare systems do not operate identically everywhere.
A disease may be more common in one region. A diagnostic test may be unavailable. A particular medicine may not be accessible. Treatment guidelines may need to account for local resources.
Reuters reported that the Rwanda work involved adapting the technology for differences in disease patterns, diagnostic resources and available treatments.
That makes localization one of the most important parts of the new initiative.
💡 Wisdom Imbibe Insight
The most interesting part of this announcement isn’t simply that AI is becoming available to more doctors.
It’s that the future of medical AI may depend less on how powerful the underlying model is and more on how well it understands the environment in which a doctor actually works.
A medical AI system can have access to an enormous amount of research. But information alone does not tell a doctor whether a particular diagnostic test is available in a rural clinic, whether a treatment can realistically be obtained, or whether a recommendation fits local healthcare conditions.
That creates a different challenge from ordinary AI deployment.
The question is no longer only, “Does the AI know the medicine?”
It is also:
“Does the AI understand the medical reality around the doctor?”
That distinction could become increasingly important as AI moves from answering general questions to supporting real-world clinical decisions.
And it explains why OpenEvidence’s emphasis on regional adaptation may matter almost as much as Anthropic’s underlying AI technology.
But Medical AI Still Has a Major Problem
Expanding access does not automatically eliminate risk.
Critics have pointed out that AI systems trained primarily on data from high-income countries may not adequately represent healthcare conditions in lower-income regions. Reuters highlighted concerns that such systems may fail to reflect local practice conditions.
This is particularly important in medicine.
A model could provide an answer that is scientifically plausible but difficult or impossible to implement locally.
For example, a recommendation might depend on:
- A laboratory test unavailable locally
- A specialist who is not present
- A medication that is difficult to obtain
- Medical equipment unavailable at the facility
- Different regional disease prevalence
- Different treatment protocols
That’s why context adaptation is more than a software feature. It can affect whether information is practically useful.
AI Should Assist Doctors, Not Replace Them
The initiative is being described as clinical decision support rather than an autonomous doctor.
That distinction matters.
OpenEvidence provides physicians with medical information and research to help inform clinical decisions. The final medical decision remains with healthcare professionals.
The potential benefit is therefore best understood as augmenting access to knowledge, particularly for doctors who may have fewer opportunities to consult specialists or expensive medical databases.
OpenEvidence also maintains security and compliance infrastructure, including SOC 2 Type 2 and HIPAA certifications for its platform.
Those certifications, however, should not be interpreted as proof that an AI recommendation is medically correct in every situation. Security, privacy and clinical accuracy are different questions.
Anthropic’s Role Goes Beyond Chatbots
The partnership also fits into a broader expansion of Anthropic’s work in science and healthcare.
The company recently established a physical biology lab as it expands its ambitions in life sciences and drug development.
That means Anthropic’s involvement in healthcare is increasingly moving beyond general-purpose AI assistants.
The company is becoming involved in areas where AI can interact with scientific research, medical information and biological problems.
At the same time, Anthropic executives have been publicly discussing the risks associated with increasingly capable AI systems.
That creates an unusual combination: the same AI industry that is debating how quickly advanced AI should develop is simultaneously finding new ways to put AI into high-stakes fields such as medicine.
Why Free Access Matters
There is also an economic dimension to the announcement.
Daniela Amodei, Anthropic’s president, said the technology has advanced enough to make the expansion possible, but that market incentives alone would not have produced it without entrepreneurial and philanthropic efforts.
That highlights a broader problem with healthcare technology.
The places that could potentially benefit enormously from better medical information are not necessarily the places where companies can generate the most revenue.
Providing the technology for free changes that equation.
Instead of asking whether physicians in poorer healthcare systems can afford another medical subscription, the initiative attempts to make the underlying information infrastructure available without charging the clinicians.
The Bigger Question: Can AI Close the Global Medical Knowledge Gap?
The medical world has always had an information-access problem.
A doctor working at a world-class medical center may have access to thousands of journals, specialists, databases and continuing education resources.
A doctor somewhere else may have dramatically fewer resources despite treating equally important medical problems.
AI could narrow that gap.
But it could also introduce a new one if the systems do not adequately understand local populations and healthcare environments.
That is why the success of this initiative will depend on more than the intelligence of Anthropic’s models.
It will depend on medical evidence, local adaptation, physician feedback, reliability, privacy and appropriate human oversight.
The technology can make information easier to reach.
It cannot eliminate the need for doctors to determine whether that information actually applies to the patient in front of them.
A New Phase for Medical AI
The Anthropic–OpenEvidence partnership represents a notable shift in how medical AI is being deployed.
Instead of focusing exclusively on wealthy healthcare markets, the companies are attempting to take clinical AI into approximately 100 countries, including places where access to medical literature and specialist expertise can be limited.
If regional adaptation works as intended, a physician with a smartphone could gain access to medical knowledge that once required an expensive institutional subscription or proximity to a major medical center.
But that promise comes with an equally important responsibility.
Medical AI must be not only knowledgeable, but context-aware.
The next test for these systems may therefore not be whether AI can answer difficult medical questions.
It may be whether it can give useful answers for the doctor, the healthcare system and the patient who actually needs them.
Read Next
Why Is Anthropic Committing $100 Million to a New Claude Partner Network?